JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB11936

Anti-Podoplanin antibody [RTD4E10] - BSA and Azide free

5

(12 Reviews)

|

(112 Publications)

Anti-Podoplanin antibody [RTD4E10] - BSA and Azide free (ab11936) is a hamster monoclonal antibody provided in a PBS only buffer for easy conjugation detecting Podoplanin in IHC-P. Suitable for Mouse.

- BSA, sodium azide, and glycerol-free for easy conjugation
- Over 80 publications
- Trusted since 2004

View Alternative Names

Gp38, Ots8, Pdpn, Podoplanin, Glycoprotein 38, OTS-8, PA2.26 antigen, Transmembrane glycoprotein E11, E11

2 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Podoplanin antibody [RTD4E10] - BSA and Azide free (AB11936)
  • IHC-P

AbReview28495****

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Podoplanin antibody [RTD4E10] - BSA and Azide free (AB11936)

ab11936 staining Podoplanin in murine skin tissue sections by Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections).Tissue was fixed in paraformaldehyde and an enzymatic antigen retrieval step was performed using Protein K. Samples were then blocked with 5% serum for 30 minutes at room temperature and then incubated with ab11936 at a 1/400 dilution for 16 hours at 4°C. The secondary used was a biotin conjugated goat anti-hamster IgG used at a 1/500 dilution.

Image courtesy of an anonymous Abreview.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Podoplanin antibody [RTD4E10] - BSA and Azide free (AB11936)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Podoplanin antibody [RTD4E10] - BSA and Azide free (AB11936)

IHC image of Podoplanin staining in a section of formalin-fixed paraffin-embedded normal mouse skin. The section was pre-treated using pressure cooker heat mediated antigen retrieval with sodium citrate buffer (pH6). Non-specific protein-protein interactions were then blocked in TBS containing 0.025% (v/v) Triton X-100, 0.3M (w/v) glycine and 1% (w/v) BSA for 1h at room temperature. The section was then incubated overnight at +4°C in TBS containing 0.025% (v/v) Triton X-100 and 1% (w/v) BSA with ab11936 at 1/250. The secondary antibody (shown in green) was ab180063 at 1/500 (Goat Anti-Syrian hamster IgG H&L (Alexa Fluor® 488) and counterstained using ab190573, Rabbit monoclonal [EP1332Y] to alpha Tubulin - Microtubule Marker (Alexa Fluor® 647), at 1/250 dilution (shown in red). Nuclear DNA was labelled with DAPI (shown in blue). The section was then mounted using Fluoromount®.

The negative control (inset) is a secondary-only assay to demonstrate low non-specific binding of the secondary antibody.

Image was taken with a confocal microscope (Leica-Microsystems, TCS SP8).

For other IHC staining systems (automated and non-automated), customers should optimize variable parameters such as antigen retrieval conditions, antibody concentrations and incubation times.

Key facts

Host species

Syrian hamster

Clonality

Monoclonal

Clone number

RTD4E10

Isotype

IgG1

Carrier free

Yes

Reacts with

Mouse

Applications

IHC-P

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Specificity

The monoclonal antibody will detect podoplanin on the surface of mouse lymphatic endothelial cells and some epithelial cell types by immunostaining or immunohistochemistry. This antibody is designed to detect podoplanin, which is also referred to as gp38 (mouse and rat) and gp36 (human).

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "1/250", "IHCP-species-notes": "<p></p>" }, "Mouse": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/250", "IHCP-species-notes": "<p></p>" } } }

Product details

What is this antibody validated in?
Anti-Podoplanin antibody [RTD4E10] - BSA and Azide free (ab11936) is a hamster monoclonal antibody and is validated for use in Immunohistochemistry (IHC-P) in Mouse samples.

Trusted by the scientific community
Anti-Podoplanin [RTD4E10] - BSA and Azide free (ab11936) was first used in a scientific publication in 2004 and has been cited over 80 times in peer-reviewed journals.

Reviewed by scientists
Anti-Podoplanin [RTD4E10] - BSA and Azide free (ab11936) has over 5 independent reviews from customers.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein G
Purification notes
Purified from cell culture supernatant.
Storage buffer
Constituents: PBS
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Podoplanin also known as gp36 and PDPN is a small transmembrane protein weighing approximately 36 kDa. It mainly expresses in lymphatic endothelial cells podocytes and various other tissues like the lung and kidney. It functions as a marker in mesothelial cells and is noticeable in histochemical studies such as mesothelioma using podoplanin staining in immunohistochemistry (IHC). Podoplanin emerges as an important tool in identifying lymphatic vessels and has significant roles in the development of certain tissues.
Biological function summary

The protein participates in maintaining the integrity of cell structures and lymphangiogenesis. This protein does not form part of a larger complex but actively interacts with different molecules. In lymphoid tissues podoplanin contributes to the proper formation of lymphatic channels and assists in platelet aggregation. These actions are pivotal in wound healing and protecting the epithelial cell layers in multiple organs.

Pathways

Podoplanin impacts the platelet activation pathway and the Lymphatic Vessel Development pathway. Its interaction with CLEC-2 (C-type lectin-like receptor 2) triggers downstream signaling leading to changes in platelet morphology and actin cytoskeleton reorganization. Podoplanin’s activation of these pathways links it to key processes that include cell migration and tissue homeostasis TGF-beta interaction also represents a significant relationship within these pathways.

Podoplanin has correlations with conditions like cancer specifically mesothelioma and squamous cell carcinoma. Dysregulation of podoplanin and its pathways may contribute to tumor progression and metastasis. In mesothelioma podoplanin interacts with other proteins like E-cadherin influencing cancer cell migration and adhesion. Its role in disease states highlights the importance of podoplanin IHC as a diagnostic tool aiding in the better understanding and identification of disease pathology.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Mediates effects on cell migration and adhesion through its different partners. During development plays a role in blood and lymphatic vessels separation by binding CLEC1B, triggering CLEC1B activation in platelets and leading to platelet activation and/or aggregation (PubMed : 14522983, PubMed : 15231832, PubMed : 17616532, PubMed : 20110424). Interaction with CD9, on the contrary, attenuates platelet aggregation and pulmonary metastasis induced by PDPN. Mediates effects on cell migration and adhesion through its different partners. Through MSN or EZR interaction promotes epithelial-mesenchymal transition (EMT) leading to ERZ phosphorylation and triggering RHOA activation leading to cell migration increase and invasiveness. Interaction with CD44 promotes directional cell migration in epithelial and tumor cells (By similarity). In lymph nodes (LNs), controls fibroblastic reticular cells (FRCs) adhesion to the extracellular matrix (ECM) and contraction of the actomyosin by maintaining ERM proteins (EZR; MSN and RDX) and MYL9 activation through association with unknown transmembrane proteins. Engagement of CLEC1B by PDPN promotes FRCs relaxation by blocking lateral membrane interactions leading to reduction of ERM proteins (EZR; MSN and RDX) and MYL9 activation (PubMed : 25347465). Through binding with LGALS8 may participate in connection of the lymphatic endothelium to the surrounding extracellular matrix (By similarity). In keratinocytes, induces changes in cell morphology showing an elongated shape, numerous membrane protrusions, major reorganization of the actin cytoskeleton, increased motility and decreased cell adhesion (PubMed : 10574709). Controls invadopodia stability and maturation leading to efficient degradation of the extracellular matrix (ECM) in tumor cells through modulation of RHOC activity in order to activate ROCK1/ROCK2 and LIMK1/LIMK2 and inactivation of CFL1 (By similarity). Required for normal lung cell proliferation and alveolus formation at birth (PubMed : 12654292). Does not function as a water channel or as a regulator of aquaporin-type water channels (By similarity). Does not have any effect on folic acid or amino acid transport (PubMed : 12032185).
See full target information Pdpn

Publications (112)

Recent publications for all applications. Explore the full list and refine your search

Nature communications 16:8742 PubMed41034192

2025

Chronic inflammation drives epididymal tertiary lymphoid structure formation and autoimmune fertility disorders in mice.

Applications

Unspecified application

Species

Unspecified reactive species

Maia L Elizagaray,Ferran Barrachina,Maria C Avenatti,Isinsu Bastepe,Angela Chen,Ainize Odriozola,Oluchi Ukairo,Vanina G Da Ros,Kiera Ottino,Nerea Subiran,Maria A Battistone

Frontiers in oncology 15:1544278 PubMed40809013

2025

PD-L1 expression in microvascular endothelial cells predicts the efficacy and side effects of anlotinib.

Applications

Unspecified application

Species

Unspecified reactive species

Yingfang Feng,Yuan Gao,Shaochuan Liu,Tingting Qin,Yan Zhang,Jing Wang,Kai Li

The Tohoku journal of experimental medicine : PubMed40074345

2025

Wnt2 Expression in Cancer-Associated Fibroblasts Precedes Lymph Node Metastasis in Orthotopic Transplantation Mouse Model of Colorectal Cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Hideaki Karasawa,Keigo Murakami,Koh Miura,Hiroyuki Sasaki,Tomoyuki Ono,Taiki Kajiwara,Akihiro Yamamura,Takashi Kamei,Shinobu Ohnuma,Toru Furukawa,Michiaki Unno

Cells 14: PubMed39996722

2025

Oversecretion of CCL3 by Irradiation-Induced Senescent Osteocytes Mediates Bone Homeostasis Imbalance.

Applications

Unspecified application

Species

Unspecified reactive species

Fanyu Zhao,Haiqing Han,Jing Wang,Jianping Wang,Jianglong Zhai,Guoying Zhu

Scientific reports 15:3485 PubMed39875798

2025

Lymphatic vessel network injury reduces local tumor control despite preservation of the tumor-draining lymph node.

Applications

Unspecified application

Species

Unspecified reactive species

Lauren N Liebman,Yang Shen,Zachary S Buchwald,Zhanna Nepiyushchikh,Zhiming Qi,Andrés J García,J Brandon Dixon

Nature communications 16:829 PubMed39827193

2025

Lymphatic platelet thrombosis limits bone repair by precluding lymphatic transporting DAMPs.

Applications

Unspecified application

Species

Unspecified reactive species

Yangkang Zheng,Lin Cong,Li Zhao,Pengyu Wang,Lianping Xing,Junling Liu,Hao Xu,Ning Li,Yongjian Zhao,Luying Yuan,Qi Shi,Xueqing Sun,Qianqian Liang,YongJun Wang

BJS open 8: PubMed39230923

2024

Role of the serosa in intestinal anastomotic healing: insights from in-depth histological analysis of human and murine anastomoses.

Applications

Unspecified application

Species

Unspecified reactive species

Marie-Christin Weber,Zoé Clees,Annalisa Buck,Adrian Fischer,Marcella Steffani,Dirk Wilhelm,Marc Martignoni,Helmut Friess,Yuval Rinkevich,Philipp-Alexander Neumann

Science (New York, N.Y.) 384:eadh4567 PubMed38935717

2024

Type I conventional dendritic cells facilitate immunotherapy in pancreatic cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Krishnan K Mahadevan,Allison M Dyevoich,Yang Chen,Bingrui Li,Hikaru Sugimoto,Amari M Sockwell,Kathleen M McAndrews,Lakshmi Kavitha Sthanam,Huamin Wang,Shabnam Shalapour,Stephanie S Watowich,Raghu Kalluri

Journal of vascular anomalies 4: PubMed38737531

2024

Trametinib inhibits lymphatic vessel invasion of bone in a mouse model of Gorham-Stout disease.

Applications

Unspecified application

Species

Unspecified reactive species

Anna L McCarter,Michael T Dellinger

PloS one 19:e0300751 PubMed38717999

2024

HIF3A gene disruption causes abnormal alveoli structure and early neonatal death.

Applications

Unspecified application

Species

Unspecified reactive species

Tomoki Kawahata,Kitaru Tanaka,Kyohei Oyama,Jun Ueda,Kensaku Okamoto,Yuichi Makino
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com